2QB4
Crystal Structure Analysis of LeuT complexed with L-leucine, sodium and desipramine
Summary for 2QB4
Entry DOI | 10.2210/pdb2qb4/pdb |
Related | 2A65 2Q6H 2Q72 2QEI |
Descriptor | Transporter, octyl beta-D-glucopyranoside, SODIUM ION, ... (6 entities in total) |
Functional Keywords | membrane protein, neurotransmitter sodium symporter, occluded, secondary amine tricyclic antidepressant, dibenzazepine, transmembrane, transport, transport protein |
Biological source | Aquifex aeolicus |
Total number of polymer chains | 1 |
Total formula weight | 60249.20 |
Authors | Singh, S.K.,Yamashita, A.,Gouaux, E. (deposition date: 2007-06-15, release date: 2007-08-21, Last modification date: 2023-08-30) |
Primary citation | Singh, S.K.,Yamashita, A.,Gouaux, E. Antidepressant binding site in a bacterial homologue of neurotransmitter transporters. Nature, 448:952-956, 2007 Cited by PubMed Abstract: Sodium-coupled transporters are ubiquitous pumps that harness pre-existing sodium gradients to catalyse the thermodynamically unfavourable uptake of essential nutrients, neurotransmitters and inorganic ions across the lipid bilayer. Dysfunction of these integral membrane proteins has been implicated in glucose/galactose malabsorption, congenital hypothyroidism, Bartter's syndrome, epilepsy, depression, autism and obsessive-compulsive disorder. Sodium-coupled transporters are blocked by a number of therapeutically important compounds, including diuretics, anticonvulsants and antidepressants, many of which have also become indispensable tools in biochemical experiments designed to probe antagonist binding sites and to elucidate transport mechanisms. Steady-state kinetic data have revealed that both competitive and noncompetitive modes of inhibition exist. Antagonist dissociation experiments on the serotonin transporter (SERT) have also unveiled the existence of a low-affinity allosteric site that slows the dissociation of inhibitors from a separate high-affinity site. Despite these strides, atomic-level insights into inhibitor action have remained elusive. Here we screen a panel of molecules for their ability to inhibit LeuT, a prokaryotic homologue of mammalian neurotransmitter sodium symporters, and show that the tricyclic antidepressant (TCA) clomipramine noncompetitively inhibits substrate uptake. Cocrystal structures show that clomipramine, along with two other TCAs, binds in an extracellular-facing vestibule about 11 A above the substrate and two sodium ions, apparently stabilizing the extracellular gate in a closed conformation. Off-rate assays establish that clomipramine reduces the rate at which leucine dissociates from LeuT and reinforce our contention that this TCA inhibits LeuT by slowing substrate release. Our results represent a molecular view into noncompetitive inhibition of a sodium-coupled transporter and define principles for the rational design of new inhibitors. PubMed: 17687333DOI: 10.1038/nature06038 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.9 Å) |
Structure validation
Download full validation report
